With the deepening of TCM research, especially the progress of evidence-based TCM, it is not impossible for TCM (or modern TCM-based agents) to enter the standardized guidelines once high-level clinical evidence is obtained, such as artemisinin and arsenic (arsenic), which are important directions in the development of TCM modernization and the main forms of TCM most readily accepted by the Western medical community. Huachansu, Jinfu Kang, acupuncture for pain relief, and Guo Lin Qigong have been subjected to rigorous evidence-based studies abroad, and Ginsenyi capsule (ginsenoside Rg3) has entered the Chinese version of the NCCN guidelines for non-small cell lung cancer. Of course, most of the current domestic TCM anti-cancer treatments are still at the stage of empirical treatment, or some small samples or basic studies, and the evidence-based level is not high, but even if they are empirical treatments, they are not equal to ineffective treatments, just that for the doctors who target the group treatment, one cannot go to replace the standard treatment (unless they cannot do any standard treatment), and the second cannot be the first choice treatment (unless there is no standard treatment). The most appropriate position is as a complementary treatment (what we used to call “adjuvant treatment” is not very appropriate). To summarize the current application of traditional Chinese medicine in the field of tumor has these purposes: to improve the tumor environment, adjust the physical status, improve immune function, regulate the balance of internal organs, reduce the symptoms of discomfort, assist in psychological adjustment, enhance communication and follow-up, treat adverse reactions, and improve the quality of life. There is no lack of clinical experience and cases in all these, but there is a lack of high-level RCT studies. For TCM oncology, we should move forward on two legs, which is the author’s view. First, traditional Chinese medicine: based on traditional theory, modern pharmacological research results can be appropriately applied, and the combination of evidence-based and disease-specific treatment can be used as a complementary treatment to standardized treatment, based entirely on individual cases, as long as experience and consensus are available, without necessarily having high-level evidence-based evidence; second, modern Chinese medicine: equivalent to the research and application of evidence-based medicine. Only the study is on TCM or modern TCM-based agents. It must be based on evidence-based and/or basic research, exposition of domestic and foreign studies, used according to strict indications (diseases), with the goal of trying to get into standardized guidelines.